Another explanation for the difference in the levels of these antibodies is the possibility that S100-B autoantibodies represent a part of the natural homeostatic immune system, thereby rendering elevated levels of S100-B autoantibodies as a possible predictor of immune competence and a protecting factor against severe COVID-19. This evidence concerns the gene S100B and COVID-19.